Septerna Inc (SEPN)
SEPN price $40.74 +1.39 +3.53%
- Ticker
- SEPN
- Price
- $40.74
- Change
- +1.39 +3.53%
- Market cap
- $1.90B
- P/E
- -72.87
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 64
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric…